Worldwide Innovative Networking Consortium Gene Expression Signature Under Development Predicts Lung Cancers Likely to Spread to Brain Premium At the WIN Symposium, a researcher from Sheba Medical Center discussed ongoing efforts to develop a 22-gene signature for predicting brain metastasis in NSCLC. WIN Consortium to Launch New Precision Oncology Study, Bank Samples for Blood Biomarker Discovery Premium On the heels of the WINTHER study, the consortium has planned a new trial called MERCURY, and will launch a blood and tissue repository. NCI Projects Aim to Improve Tools, Pre-Clinical Models for Precision Oncology Research Premium The NCI will launch a lab network to provide researchers with centralized assays for conducting genomic and pharmacodynamic analysis for molecularly targeted drugs. HTG Molecular Posts 5 Percent Drop in Q2 Revenues While the company reported an increase in revenues from biopharma partners, this gain was more than offset by lower consumable sales. Illumina Joins WIN Consortium Illumina is the latest to join the consortium, which is focused on personalizing cancer care. Apr 22, 2015 WIN Consortium Describes Development of SIMS Algorithm to Personalize NSCLC Triplet Therapies Premium Jun 22, 2011 Q&A: MD Anderson's Mendelsohn Discusses WIN Consortium's Effort to Advance Personalized Cancer Drugs Premium Breaking News Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen Consanguinity Contributes to Common Disease Risk, Study Suggests Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.